BioPharma Dive May 3, 2021
Jonathan Andrus, Chief Business Officer, Clinical Ink

Some of the most time- and cost-consuming components of clinical research center on gathering, analyzing, and reporting data. To improve efficiency, many clinical trial sponsors have shifted to electronic clinical outcome assessments (eCOA), including electronic patient-reported outcome (ePRO) tools.

In most cases, patients enter data using apps installed on provisioned devices. At a time when 81% of Americans own a smartphone, why not use the device they rely on every day?

Using patients’ mobile devices, as either a stand-alone solution to collect participant data or as part of a hybrid option that also incorporates provisioned devices, enhances patient centricity. That’s the theory behind the bring your own device (BYOD) strategy — a viable option for many clinical trials and a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, mHealth, Patient / Consumer, Pharma, Pharma / Biotech, Technology
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
AI In Healthcare: A New Era Of Personalized Patient Care

Share This Article